Myocardial Perfusion Imaging
Prior COVID-19 should not impact pharmacological MPI stress testing
Prior COVID‐19 was not associated with a higher risk for complications during and after pharmacologic myocardial perfusion imaging stress testing, data from a large claims database analysis show.
A tribute to Barry L. Zaret, MD
Cardiology Today Editorial Board Member Barry L. Zaret, MD, MASNC, a pioneer in the field of nuclear cardiology, recently passed away, the American Society for Nuclear Cardiology announced.
Coronary CTA superior to stress myocardial perfusion imaging for invasive FFR diagnosis
Using coronary CTA for comprehensive anatomic interpretation was superior to functional imaging to determine fractional flow reserve, researchers found in the CREDENCE trial.
Automated myocardial perfusion imaging improves MACE risk stratification
Adding quantitative analysis from automated myocardial perfusion imaging to visual reading improved risk stratification for prediction of major adverse cardiac events, according to new data from the REFINE SPECT registry.
Diabetes, minimal perfusion deficit increase risk for major adverse CV events
Even a small perfusion deficit substantially amplifies risk for major adverse cardiovascular events among adults with diabetes vs. those without, according to findings published in Diabetes Care.
Noninvasive testing after ED visit for chest pain may reduce event rates
Patients who underwent noninvasive diagnostic testing after evaluation for chest pain in the ED had a lower observed rate of CV death or MI, according to a retrospective cohort study published in the Journal of the American Heart Association.